Lexicon Pharma

$3.06 0.00% ($0.00)

Get ready to invest

About Lexicon Pharma

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of treatments for human disease. The Company's drug programs include Sotagliflozin and LX9211. The Company also has a number of additional compounds into various stages of clinical and preclinical development. The Company’s LX9211 is an orally-delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company intends to initiate a Phase IIa clinical trial evaluating the safety and tolerability of LX9211 and its effects on diabetic peripheral neuropathic (DPN) pain. Its Sotagliflozin is an orally-delivered small molecule compound that is being developed for the treatment of type I diabetes and type II diabetes, heart failure and chronic kidney disease.

Popular Stocks	Price	Change
AMC Entertainment AMC	$15.095 5.3%	5.3%
AT&T T	$24.295 0.19%	0.19%
AMD AMD	$106.66 3.66%	3.66%
Nvidia NVDA	$225.9801 0.76%	0.76%
FuelCell FCEL	$3.685 4.53%	4.53%
Micron Technology MU	$81.49 0.59%	0.59%
Ford F	$19.9676 0.29%	0.29%
Apple AAPL	$163.05 2.1%	2.1%
NIO NIO	$22 2.91%	2.91%